Abigail Pohl Pierce

Abigail Pohl Pierce is a Vice President at NewVale Capital.

Prior to joining NewVale, Abigail was an investor with the Merck Global Health Innovation Fund, investing across the pharmaceutical value chain and supporting partnerships between portfolio companies and the broader Merck organization. Earlier in her career, she worked as a management consultant at Accenture, advising life sciences companies on digital health and innovation strategies.

Abigail holds a BA in Economics, with a minor in Global Health, from Middlebury College.